Datasets (28,470)

effects of ZMYM2 KO on gene expression of pluripotent and differentiating ESCs

Extensive proteomic and transcriptomic changes quench the TCR/CD3 activation signal of latently HIV-1 infected T cells

Cell-intrinsic Innate Immune Responses against Chikungunya Virus in a Human Ex Vivo Synovial Fibroblast Model

RNA-seq analysis in human REH pre-B lymphoblastic cells in response to XIST-KD

Gene regulation gravitates towards either addition or multiplication when combining the effects of two signals

Seminal Plasma-Derived Extracellular-Vesicle Fractions from HIV-Infected Men Exhibit Unique MicroRNA Signatures and Induce a Proinflammatory Response in Cells Isolated from the Female Reproductive Tract

RNA-Seq analysis of human CD56bright NK cells cultured with ascorbic acid

Transcriptomic profiling in NTAPP-exposed human dermal papilla cells.

Naïve human embryonic stem cells can give rise to cells with trophoblast-like transcriptome and methylome [RNA-Seq]

mRNA profiling after knockdown of lncRNA Cyrano

Transcriptional response of fibronectin fragment treatment in human articular chondrocytes

RNA-Seq of Human iPSC-cardiomyocytes infected with SARS-CoV-2

IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [METTL KD in PANC-1 (polyA RNA)]

IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in PANC-1 (total RNA)]

IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [E2F1-3 KD in PANC-1 (polyA RNA)]